F2-isoprostanes
Selected indexed studies
- F2-isoprostanes and the liver. (Prostaglandins Other Lipid Mediat, 2003) [PMID:14626497]
- F2-isoprostanes are not just markers of oxidative stress. (Free Radic Biol Med, 2008) [PMID:17997380]
- Usefulness of F2-isoprostanes in early prognostication after cardiac arrest: a topical review of the literature and meta-analysis of preclinical data. (Biomarkers, 2020) [PMID:32274952]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- F2-isoprostanes and the liver. (2003) pubmed
- F2-isoprostanes are not just markers of oxidative stress. (2008) pubmed
- Usefulness of F2-isoprostanes in early prognostication after cardiac arrest: a topical review of the literature and meta-analysis of preclinical data. (2020) pubmed
- F2-isoprostanes in Alzheimer and other neurodegenerative diseases. (2005) pubmed
- From Biomarker to Mechanism? F2-isoprostanes in Pulmonary Fibrosis. (2022) pubmed
- F2-isoprostanes as markers of oxidative stress in vivo: an overview. (2005) pubmed
- F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications. (2008) pubmed
- F2-isoprostanes as markers of oxidant stress: an overview. (2005) pubmed
- Antioxidant modulation of F2-isoprostanes in humans: a systematic review. (2014) pubmed
- Association of continuous positive airway pressure with F2-isoprostanes in adults with obstructive sleep apnea: a meta-analysis. (2019) pubmed